Camber expands its portfolio with Cisatracurium Besylate Injection, USP [sis-AT-ra-KURE-ee-um], generic to Nimbex®, broadening access to important treatment options.
Cisatracurium Besylate Injection, USP, is a nondepolarizing neuromuscular blocker indicated:
- as an adjunct to general anesthesia to facilitate tracheal intubation in adults and in pediatric patients 1 month to 12 years of age
- to provide skeletal muscle relaxation during surgery in adults and in pediatric patients 2 to 12 years of age as a bolus or infusion maintenance
- for mechanical ventilation in the ICU in adults
Camber’s Cisatracurium Besylate Injection, USP is available in:
- 10 mg/5 mL (2 mg/mL) | 10 x 5 mL Single-dose Vials
- 200 mg/20 mL (10 mg/mL) | 10 x 20 mL Single-dose Vials
- 20 mg/10 mL (2 mg/mL) | 10 x 10 mL Multiple-dose Vials
To learn more about Cisatracurium Besylate Injection Single-dose Vials, click here.
To learn more about Cisatracurium Besylate Injection Multiple-dose Vials, click here.
